Rapid development of two factor IXa inhibitors from hit to lead.
Parker, D.L., Walsh, S., Li, B., Kim, E., Sharipour, A., Smith, C., Chen, Y.H., Berger, R., Harper, B., Zhang, T., Park, M., Shu, M., Wu, J., Xu, J., Dewnani, S., Sherer, E.C., Hruza, A., Reichert, P., Geissler, W., Sonatore, L., Ellsworth, K., Balkovec, J., Greenlee, W., Wood, H.B.(2015) Bioorg Med Chem Lett 25: 2321-2325
- PubMed: 25937013 
- DOI: https://doi.org/10.1016/j.bmcl.2015.04.025
- Primary Citation of Related Structures:  
4YZU, 4Z0K - PubMed Abstract: 
Two high-throughput screening hits were investigated for SAR against human factor IXa. Both hits feature a benzamide linked to a [6-5]-heteroaryl via an alkyl amine. In the case where this system is a benzimidazolyl-ethyl amine the binding potency for the hit was improved >500-fold, from 9 μM to 0 ...